Future of DNA Vaccines Market 2025: Strategic Insights, Projections Emerging Vaccines | Top 5 Companies are , ASTELLAS PHARMA, Dynavax Technologies, Protein Sciences Corp, Inovio Pharmaceuticals, Inc, Dendreon Corporation

Global DNA Vaccines Market is estimated to reach at a CAGR of 42.03% during the forecast period (2024-2031).

DataM Intelligence has published a new research report on "DNA Vaccines Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

United States: Recent Industry Developments
✅ October 2025: Inovio Pharmaceuticals advanced clinical trials of its DNA vaccine candidates targeting emerging infectious diseases.
✅ September 2025: Moderna announced collaboration to develop next-generation DNA vaccines with enhanced delivery platforms.
✅ August 2025: The FDA approved new DNA vaccine formulations for personalized cancer immunotherapy.

Japan: Recent Industry Developments
✅ October 2025: Takeda Pharmaceutical expanded research on DNA vaccines for infectious and chronic diseases.
✅ September 2025: Collaboration between Japanese biotech firms and academic institutes accelerated DNA vaccine platform innovations.
✅ August 2025: Government funding increased for DNA vaccine development targeting endemic viral infections.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/dna-vaccines-market?kb

Latest M&A Activity

Merck expanded its partnerships with biotech firms to accelerate DNA vaccine development for emerging infectious diseases, focusing on scalable manufacturing and rapid deployment capabilities。​

Several collaborations between pharmaceutical companies and technology firms are enhancing DNA delivery platforms and immunogenicity, accelerating pathway to market for novel DNA vaccines.

Key Players:

Inovio Pharmaceuticals, Inc., Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals, GlaxoSmithKline Corp and Protein Sciences Corp.

Recent Product Launches and Innovations

IMUNON announced progress with its next-generation DNA vaccine platform PlaCCine®, based on Theraplas® DNA immunotherapy technology, showing promising results in phase 1 trials targeting COVID-19 Omicron variant XBB.1.5, indicating potent immunity with single-dose administration.​

Zydus Cadila's ZyCoV-D, the world's first DNA-based COVID-19 vaccine, continues to demonstrate high safety and immunogenicity in children and adults, with ongoing clinical evaluations exploring optimized two-dose regimens instead of three.​

Advances in thermostable DNA vaccine formulations potentially enable improved storage and distribution in remote areas, expanding global access to immunizations.

Growth Forecast Projected:

The Global DNA Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global DNA Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=dna-vaccines-market?kb

Key Segments:

By Type: (Human DNA Vaccines, Animal DNA Vaccines)

By Application: (Human Diseases, Veterinary Diseases)

By End User: (Human Health, Animal Health, Research)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among DNA Vaccines producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze DNA Vaccines revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/dna-vaccines-market?kb

Ongoing Clinical Trials

Multiple phase 1 and phase 2 trials are underway evaluating DNA vaccines for viruses including SARS-CoV-2 variants, HPV, and tropical infectious diseases, with a focus on safety, immune response durability, and alternative delivery methods like needle-free injection and electroporation.​

Trials investigating DNA-launched live-attenuated vaccines demonstrate potential for a new class of DNA vaccines combining advantages of traditional live vaccines with DNA technology.

Get 2-Day Free Trial + 50% OFF DataM Subscription@: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.